- Poster presentation
- Open access
- Published:
B lymphocyte stimulator, interferon-α and HMGB 1 interrelation in childhood onset systemic lupus erythematosus: associations with disease activity and severity
Pediatric Rheumatology volume 12, Article number: P321 (2014)
Introduction
The role of B lymphocyte stimulator (Blys) in Childhood onset Systemic Lupus Erythematosus (cSLE) has not been elucidated.
Objectives
To investigate the role of Blys and its association with biomarkers related with the cSLE disease activity and severity.
Methods
34 cSLE patients (study group), 51 with other rheumatic or autoimmune diseases and 26 healthy children (control groups) were studied. For evaluating the disease activity, SLEDAI and ECLAM scores were used. For estimating the disease severity the criteria were: involvement of 3 vital organs (kidneys or CNS or blood or combination of ≥2 organs), increased anti-dsDNA titres, low C3 /C4 concentrations and high concentrations of serum IFN-α and HMGB1 (High mobility group box 1) protein.
Results
Mean Blys levels were significantly higher in cSLE patients in respect to patients of all control groups, in patients with active as compared with patients with inactive disease and in patients with vital organ involvement as compared with patients without such involvement. Moreover, mean Blys levels were positively correlated with anti-DNA titer, IFN-α and HMGB1 levels but negatively correlated with C3 /C4 concentrations.
Conclusion
Taking together, results of our study indicate that: high levels of Blys are mainly found in serum of jSLE patients and they may be involved in the increased anti-DNA plus other autoantibody production. Moreover, they are associated with the disease activity and severity, meaning that Blys is a specific biomarker for the selection of patients who will need more aggressive and possibly more targeted than conventional therapy.
Disclosure of interest
None declared
Author information
Authors and Affiliations
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Kanakoudi-Tsakalidou, F., Tzimouli, V., Farmaki, E. et al. B lymphocyte stimulator, interferon-α and HMGB 1 interrelation in childhood onset systemic lupus erythematosus: associations with disease activity and severity. Pediatr Rheumatol 12 (Suppl 1), P321 (2014). https://doi.org/10.1186/1546-0096-12-S1-P321
Published:
DOI: https://doi.org/10.1186/1546-0096-12-S1-P321